Nuuvera to Acquire Remaining Interest in Avanti Rx Analytics

- February 20th, 2018

Nuuvera announced it entered a letter of intent to acquire the 49 percent minority interest in Avanti Rx Analytics.

Nuuvera (TSXV:NUU) announced it entered a letter of intent to acquire the 49 percent minority interest in Avanti Rx Analytics.

As quoted in the press release:

As part of the acquisition, the Company also anticipates acquiring Avanti’s facility at 135 Devon Road, Brampton, Ontario (together, the “Avanti Transaction“). Total consideration for the Avanti Transaction is expected to be approximately $43 million.

Ronald Schmeichel, Chairman of Nuuvera, said, “the acquisition of Avanti is an important step in the history of Nuuvera and is expected to result in synergies at the combined Nuuvera / Aphria which will enhance the value of the Arrangement to shareholders of Nuuvera.”

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Leave a Reply

Your email address will not be published. Required fields are marked *